Managers / Q2 2021 · view latest →
Hillcrest Wealth Advisors - NY, LLC
CIK 0001767121 · 100 VILLAGE COURT, SUITE 202, HAZLET, NJ, 07730 · 732.837.4455
Summary
Hillcrest Wealth Advisors - Ny, LLC reported $165M in U.S.-listed holdings across 51 positions for Q2 2021.
The portfolio is heavily concentrated: IWM alone accounts for 35.6% of reported value.
Compared with Q1 2021, the fund opened 7 new positions and exited 9.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 92.7% · $153M
- Common Stock · 7.0% · $11M
- REIT · 0.4% · $588,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| IJRISHARES TR | NEW | +6.6K | 6.6K | +$748,000 | $748,000 |
| EEMISHARES TR | NEW | +6.4K | 6.4K | +$352,000 | $352,000 |
| IAUISHARES GOLD TR | NEW | +10.3K | 10.3K | +$349,000 | $349,000 |
| BNDVANGUARD BD INDEX FDS | NEW | +3.2K | 3.2K | +$279,000 | $279,000 |
| MSFTMICROSOFT CORP | NEW | +921 | 921 | +$249,000 | $249,000 |
| GOOGALPHABET INC | NEW | +96 | 96 | +$241,000 | $241,000 |
| ONCONOVA THERAPEUTICS INC | NEW | +16.7K | 16.7K | +$116,000 | $116,000 |
| BABOEING CO | SOLD OUT | −2.3K | 0 | −$586,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IWMISHARES TR | RUSSELL 2000 ETF · RUS 2000 VAL ETF · RUS 2000 GRW ETF · CORE US AGGBD ET · RUS 1000 VAL ETF · RUS 1000 GRW ETF · 0-5 YR TIPS ETF · TIPS BD ETF · RUS 1000 ETF · CORE S&P SCP ETF · MSCI EAFE ETF · MSCI EMG MKT ETF · CHINA LG-CAP ETF | 35.63% | $59M | 334.4K |
| 2 | VOOVANGUARD INDEX FDS | S&P 500 ETF SHS · GROWTH ETF · VALUE ETF · REAL ESTATE ETF · TOTAL STK MKT | 21.99% | $36M | 116.0K |
| 3 | VEUVANGUARD INTL EQUITY INDEX F | ALLWRLD EX US · FTSE EMR MKT ETF | 11.42% | $19M | 310.0K |
| 4 | SPYSPDR S&P 500 ETF TRhistory → | TR UNIT | 9.05% | $15M | 34.9K |
| 5 | VEAVANGUARD TAX-MANAGED INTL FDhistory → | FTSE DEV MKT ETF | 3.13% | $5M | 100.2K |
| 6 | BRK/BBERKSHIRE HATHAWAY INC DELhistory → | CL B NEW | 2.77% | $5M | 16.4K |
| 7 | XLVSELECT SECTOR SPDR TR | SBI HEALTHCARE · FINANCIAL · ENERGY · SBI INT-INDS · SBI CONS DISCR · SBI CONS STPLS | 2.47% | $4M | 52.8K |
| 8 | SDYSPDR SER TR | S&P DIVID ETF · S&P BIOTECH | 2.34% | $4M | 31.0K |
| 9 | GPNGLOBAL PMTS INChistory → | COM | 2.06% | $3M | 18.2K |
| 10 | DBX ETF TR | XTRACK MSCI EAFE | 1.90% | $3M | 83.5K |
| 11 | VCITVANGUARD SCOTTSDALE FDShistory → | INT-TERM CORP | 1.27% | $2M | 22.1K |
| 12 | VGTVANGUARD WORLD FDS | INF TECH ETF · CONSUM STP ETF | 1.24% | $2M | 6.1K |
| 13 | BSVVANGUARD BD INDEX FDS | SHORT TRM BOND · TOTAL BND MRKT | 1.00% | $2M | 20.0K |
| 14 | IEMGISHARES INC | CORE MSCI EMKT | 0.75% | $1M | 18.4K |
| 15 | GOOGLALPHABET INC | CAP STK CL A · CAP STK CL C | 0.72% | $1M | 483 |
| 16 | JPMJPMORGAN CHASE & CO | COM | 0.41% | $670,000 | 4.3K |
| 17 | AREALEXANDRIA REAL ESTATE EQ IN | COM | 0.36% | $588,000 | 3.2K |
| 18 | ABXBARRICK GOLD CORP | COM | 0.31% | $517,000 | 25.0K |
| 19 | GLDSPDR GOLD TR | GOLD SHS | 0.28% | $464,000 | 2.8K |
| 20 | IAUISHARES GOLD TR | ISHARES NEW | 0.21% | $349,000 | 10.3K |
| 21 | AAPLAPPLE INC | COM | 0.18% | $297,000 | 2.2K |
| 22 | BMYBRISTOL-MYERS SQUIBB CO | COM | 0.15% | $254,000 | 3.8K |
| 23 | MSFTMICROSOFT CORP | COM | 0.15% | $249,000 | 921 |
| 24 | PNCPNC FINL SVCS GROUP INC | COM | 0.14% | $234,000 | 1.2K |
| 25 | ONCONOVA THERAPEUTICS INC | COM NEW | 0.07% | $116,000 | 16.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $247M | 51 | Apr 28, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $232M | 52 | Jan 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $222M | 53 | Oct 20, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $213M | 49 | Jul 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $202M | 48 | Apr 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $210M | 50 | Jan 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $200M | 47 | Oct 17, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $186M | 47 | Jul 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $185M | 46 | Apr 11, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $181M | 45 | Jan 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $176M | 47 | Oct 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $169M | 47 | Jul 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $169M | 48 | May 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $167M | 50 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $158M | 52 | Nov 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $165M | 50 | Aug 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $181M | 48 | May 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $186M | 52 | Feb 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $169M | 52 | Oct 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $165M | 51 | Aug 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $164M | 53 | Apr 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $149M | 51 | Feb 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $141M | 59 | Oct 21, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $116M | 44 | Aug 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $100M | 41 | Apr 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $120M | 38 | Jan 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $116M | 38 | Oct 17, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $119M | 41 | Aug 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $114M | 41 | May 10, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $108M | 54 | Feb 8, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.